Over the past ten years, Progressive has demonstrated remarkable underwriting discipline, delivering an average combined ratio of 92.2% while scaling gross written premiums from $19.6 billion in 2014 to $65.5 billion in 2024. The company has maintained an expense ratio below 20% throughout this period, enabling underwriting profitability that has withstood varying market cycles. This disciplined approach has translated into consistent margin preservation even as Progressive aggressively expanded its book of business, positioning the insurer for durable long-term returns.

Among twenty-two brokerages currently covering Progressive, two recommend sell, twelve recommend hold, seven recommend buy and one recommends strong buy, resulting in an average consensus rating of “Hold.” Analysts’ twelve-month target prices aggregate to approximately $261, reflecting a moderate upside outlook tied to expected improvement in loss frequency and conservative reserve releases. Recent changes include a downgrade by Zacks Research in October and an upgrade by Barclays in December, while major firms such as Citigroup and Morgan Stanley have maintained buy and underweight stances respectively, underscoring divergent views on near-term profitability versus valuation metrics.

Insider transactions over the past three months show net sales of 9,034 shares valued at approximately $2.05 million, including a block trade by CFO John P. Sauerland of 5,000 shares and a sale of 1,344 shares by Steven Broz. Insiders now hold 0.34% of the company’s shares. On the institutional side, 85.34% of shares are held by funds; notable movements include a 15.6% increase by Brighton Jones LLC, a new position by Revolve Wealth Partners LLC, and a 37.5% boost by HBW Advisory Services LLC. These shifts suggest ongoing portfolio reallocations rather than decisive repositioning, reflecting broad confidence in Progressive’s underwriting model.